Viewing Study NCT04478357


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-02-12 @ 8:44 AM
Study NCT ID: NCT04478357
Status: COMPLETED
Last Update Posted: 2021-05-07
First Post: 2020-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurogenic Detrusor Overactivity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None Fesoterodine beads- in-capsule View
None bioequivalence View
None Pharmacokinetics View
None Toviaz View